UBTF Mutation Causes Complex Phenotype of Neurodegeneration and Severe Epilepsy in Childhood

Abstract

Introduction Neurodegenerative diseases of childhood present with progressive decline in cognitive, social, and motor function and are frequently associated with seizures in different stages of the disease. Here we report a patient with severe progressive neurodegeneration with drug-resistant epilepsy of unknown etiology from the age of 2 years.

Methods and Results Using whole exome sequencing, we found heterozygous missense de novo variant c.628G > A (p.Glu210Lys) in the UBTF gene. This variant was recently described as de novo in 11 patients with similar neurodegeneration characterized by developmental decline initially confined to motor development followed by language regression, appearance of an extrapyramidal movement disorder, and leading to severe intellectual disability. In 3 of the 11 patients described so far, seizures were also present.

Conclusions Our report expands the complex phenotype of neurodegeneration associated with the c.628G > A variant in the UBTF gene and helps to clarify the relation between this one single recurrent pathogenic variant described in this gene to date and its phenotype. The UBTF gene should be considered a novel candidate gene in neurodegeneration with or without epilepsy.

Keywords

UBTF - neurodegeneration - epilepsy - whole exome sequencing - trio analysis

• References

• 1 Chen T, Giri M, Xia Z, Subedi YN, Li Y. Genetic and epigenetic mechanisms of epilepsy: a review. Neuropsychiatr Dis Treat 2017; 13: 1841-1859
• 2 Pandolfo M. Pediatric epilepsy genetics. Curr Opin Neurol 2013; 26 (02) 137-145
• 3 Edvardson S, Nicolae CM, Agrawal PB. , et al. Heterozygous de novo UBTF gain-of-function variant is associated with neurodegeneration in childhood. Am J Hum Genet 2017; 101 (02) 267-273
• 4 Toro C, Hori RT, Malicdan MCV. , et al; C4RCD Research Group. A recurrent de novo missense mutation in UBTF causes developmental neuroregression. Hum Mol Genet 2018; 27 (04) 691-705
• 5 Staněk D, Laššuthová P, Štěrbová K. , et al. Detection rate of causal variants in severe childhood epilepsy is highest in patients with seizure onset within the first four weeks of life. Orphanet J Rare Dis 2018; 13 (01) 71
• 6 Neupauerová J, Štěrbová K, Vlčková M. , et al. Two novel variants affecting CDKL5 transcript associated with epileptic encephalopathy. Genet Test Mol Biomarkers 2017; 21 (10) 613-618
• 7 Ramu A, Noordam MJ, Schwartz RS. , et al. DeNovoGear: de novo indel and point mutation discovery and phasing. Nat Methods 2013; 10 (10) 985-987